Analysts Expect Modest 2012 Contribution from HPV Assay for Gen-Probe | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment analysts have weighed in on the US Food and Drug Administration's clearance of Gen-Probe's Aptima HPV assay, saying that they expect a modest revenue contribution in 2012 but a potentially significant ramp in sales over the following two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.